{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:26:57Z","timestamp":1788607617845,"version":"build-2803163510"},"reference-count":85,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:00:00Z","timestamp":1740873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The University of Georgia Research Foundation","award":["UL1TR002378"],"award-info":[{"award-number":["UL1TR002378"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Individuals with HIV on combined antiretroviral therapy (ART) with virologic suppression exhibit chronic immune activation and immune dysfunction. Numerous studies have shown that human milk oligosaccharide (HMO) controls the postnatal transmission of HIV-1, but its effect on adult HIV-1 infection is not known. The purpose of this study was to investigate the anti-HIV activity of Lacto-N-fucopentaose III (LNFPIII) in adult blood-borne macrophages. Methods: Primary human monocyte-derived macrophages from the blood of HIV-seronegative individuals were infected with HIV and treated with or without dextran-conjugated LNFPIII (P3DEX). HIV replication was measured by quantifying the accumulation of HIV Gag p24 in the culture supernatants by ELISA. The quantities of chemokines MIP-1\u03b1, MIP-1\u03b2, and CCL5 in the culture supernatant were also measured by ELISA. The expression of IL-1\u03b2, IL-18, TNF\u03b1, IL-10, BECN1, and housekeeping gene HuPO in the macrophages was determined by qRT PCR. The expression of NF-kB, LC3, p62, and \u03b2-actin was measured by immunoblotting. Results: We found that P3DEX controls HIV replication without affecting HIV binding and\/or internalization by human macrophages. The treatment of HIV-infected macrophages with P3DEX increased the quantity of beta (\u03b2)-chemokines MIP-1\u03b1, CCL5, and MIP-1\u03b2, which are known to have anti-HIV activity. Furthermore, the treatment of HIV-infected macrophages with P3DEX increased autophagic flux in a TLR8-dependent manner and ameliorated the expression of proinflammatory cytokines. These results suggest that P3DEX is a prominent milk-derived sugar that simultaneously augments anti-viral mechanisms and controls immune activation. These findings prudently justify the use and clinical development of P3DEX as a host-directed therapeutic option for people living with HIV.<\/jats:p>","DOI":"10.3390\/nu17050890","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:41:51Z","timestamp":1741066911000},"page":"890","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Human Milk Oligosaccharide Lacto-N-Fucopentaose III Conjugated to Dextran Inhibits HIV Replication in Primary Human Macrophages"],"prefix":"10.3390","volume":"17","author":[{"given":"Tablow Shwan","family":"Media","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhini","family":"Ramesh","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia Isa","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Njideka","family":"Ubaka","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald A.","family":"Harn","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Norberg","sequence":"additional","affiliation":[{"name":"Department of Biochemistry-BMC, Uppsala University, 753 10 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-6138","authenticated-orcid":false,"given":"Ankita","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,2]]},"reference":[{"key":"ref_1","unstructured":"Geneva: Joint United Nations Programme on HIV\/AIDS (2023, October 01). UNAIDS 2021 Reference 2021. Available online: https:\/\/digitallibrary.un.org\/record\/3949533?ln=en?ln=en."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1089\/088922202320935429","article-title":"Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy","volume":"18","author":"Almeida","year":"2002","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: Collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kuller, L.H., Tracy, R., Belloso, W., De Wit, S., Drummond, F., Lane, H.C., Ledergerber, B., Lundgren, J., Neuhaus, J., and Nixon, D. (2008). Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050203"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/COH.0000000000000244","article-title":"Immune activation and HIV: An enduring relationship","volume":"11","author":"Sereti","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104304","DOI":"10.1016\/j.cellimm.2021.104304","article-title":"Residual immune activation in HIV-Infected individuals expands monocytic-myeloid derived suppressor cells","volume":"362","author":"Singh","year":"2021","journal-title":"Cell Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","article-title":"The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"Wada","year":"2015","journal-title":"AIDS"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/QAD.0b013e328346be29","article-title":"High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors","volume":"25","author":"Aslangul","year":"2011","journal-title":"AIDS"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/nu3121042","article-title":"Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection","volume":"3","author":"Ahrne","year":"2011","journal-title":"Nutrients"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Freeman, M.L., Clagett, B.M., Moisi, D., Yeh, E., Morris, C.D., Ryu, A., Rodriguez, B., Stein, J.H., Deeks, S.G., and Currier, J.S. (2022). Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.924718"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/infdis\/jiq115","article-title":"High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: Results of a double-blind randomized placebo controlled clinical trial","volume":"203","author":"Ganesan","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mi.2011.15","article-title":"Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the \u201cCOPA\u201d pilot randomized trial","volume":"4","author":"Gori","year":"2011","journal-title":"Mucosal Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12082","DOI":"10.1128\/JVI.01466-10","article-title":"Reduction of immune activation with chloroquine therapy during chronic HIV infection","volume":"84","author":"Murray","year":"2010","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-4690-4-6","article-title":"Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes","volume":"4","author":"Naarding","year":"2007","journal-title":"Retrovirology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"ofab550","DOI":"10.1093\/ofid\/ofab550","article-title":"A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People with HIV on Antiretroviral Therapy","volume":"8","author":"Presti","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/cid\/ciy414","article-title":"Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study)","volume":"68","author":"Vallejo","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm.2111","article-title":"HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects","volume":"16","author":"Buzon","year":"2010","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/QAI.0b013e318273015f","article-title":"Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 study","volume":"61","author":"Cuzin","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gandhi, R.T., Zheng, L., Bosch, R.J., Chan, E.S., Margolis, D.M., Read, S., Kallungal, B., Palmer, S., Medvik, K., and Lederman, M.M. (2010). The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: A randomized controlled trial. PLoS Med., 7.","DOI":"10.1371\/journal.pmed.1000321"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1097\/QAD.0b013e3283584521","article-title":"The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients","volume":"26","author":"Vallejo","year":"2012","journal-title":"AIDS"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/infdis\/jis376","article-title":"A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4(+) T-cell recovery despite sustained virologic suppression: ACTG A5256","volume":"206","author":"Wilkin","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/infdis\/jir559","article-title":"Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: A randomized controlled trial","volume":"204","author":"Byakwaga","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/infdis\/jir667","article-title":"Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy","volume":"204","author":"Dahl","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gutierrez, C., Diaz, L., Vallejo, A., Hernandez-Novoa, B., Abad, M., Madrid, N., Dahl, V., Rubio, R., Moreno, A.M., and Dronda, F. (2011). Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: Effect on T cells latently infected. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027864"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/QAD.0b013e32833ef7bb","article-title":"Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy","volume":"24","author":"Yukl","year":"2010","journal-title":"AIDS"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1742-4690-6-51","article-title":"HIV interactions with monocytes and dendritic cells: Viral latency and reservoirs","volume":"6","author":"Coleman","year":"2009","journal-title":"Retrovirology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1570162052772951","article-title":"Pathogenesis of macrophage tropic HIV-1","volume":"3","author":"Gorry","year":"2005","journal-title":"Curr. HIV Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13365-015-0346-y","article-title":"Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment","volume":"21","author":"Rappaport","year":"2015","journal-title":"J. Neurovirol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1172\/JCI115559","article-title":"Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)","volume":"89","author":"Rich","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nm0703-853","article-title":"HIV-1 pathogenesis","volume":"9","author":"Stevenson","year":"2003","journal-title":"Nat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2014-08-596775","article-title":"HIV-1 reprograms the migration of macrophages","volume":"125","author":"Verollet","year":"2015","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wong, M.E., Jaworowski, A., and Hearps, A.C. (2019). The HIV Reservoir in Monocytes and Macrophages. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01435"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/jn\/136.8.2127","article-title":"Recent advances on structure, metabolism, and function of human milk oligosaccharides","volume":"136","author":"Bode","year":"2006","journal-title":"J. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1111\/j.1753-4887.2009.00239.x","article-title":"Human milk oligosaccharides: Prebiotics and beyond","volume":"67","author":"Bode","year":"2009","journal-title":"Nutr. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.nutr.20.1.699","article-title":"Oligosaccharides in human milk: Structural, functional, and metabolic aspects","volume":"20","author":"Kunz","year":"2000","journal-title":"Annu. Rev. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3945\/ajcn.112.039503","article-title":"Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding","volume":"96","author":"Bode","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1017\/S0007114508025804","article-title":"Human milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN)","volume":"101","author":"Hong","year":"2009","journal-title":"Br. J. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1128\/AAC.00593-06","article-title":"Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells","volume":"50","author":"Naarding","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1172\/JCI25105","article-title":"Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes","volume":"115","author":"Naarding","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1570162033352129","article-title":"Sugar and spice: Viral envelope-DC-SIGN interactions in HIV pathogenesis","volume":"1","author":"Su","year":"2003","journal-title":"Curr. HIV Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nri1960","article-title":"Dendritic-cell interactions with HIV: Infection and viral dissemination","volume":"6","author":"Wu","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/nm.2962","article-title":"Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways","volume":"18","author":"Bhargava","year":"2012","journal-title":"Nat. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"107012","DOI":"10.1016\/j.ntt.2021.107012","article-title":"Delayed treatment with the immunotherapeutic LNFPIII ameliorates multiple neurological deficits in a pesticide-nerve agent prophylactic mouse model of Gulf War Illness","volume":"87","author":"Carpenter","year":"2021","journal-title":"Neurotoxicol. Teratol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.clim.2011.12.006","article-title":"Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis","volume":"142","author":"Zhu","year":"2012","journal-title":"Clin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1128\/IAI.01293-13","article-title":"Immunomodulatory glycan lacto-N-fucopentaose III requires clathrin-mediated endocytosis to induce alternative activation of antigen-presenting cells","volume":"82","author":"Srivastava","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Tundup, S., Srivastava, L., Norberg, T., Watford, W., and Harn, D. (2015). A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137495"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"102326","DOI":"10.1016\/j.tube.2023.102326","article-title":"IL-27 inhibits anti- Mycobacterium tuberculosis innate immune activity of primary human macrophages","volume":"139","author":"Gollnick","year":"2023","journal-title":"Tuberculosis"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1039\/C5CC01330E","article-title":"Sequential one-pot multienzyme (OPME) synthesis of lacto-N-neotetraose and its sialyl and fucosyl derivatives","volume":"51","author":"Chen","year":"2015","journal-title":"Chem. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1021\/acs.joc.6b00478","article-title":"Chemoenzymatic Synthesis of a Library of Human Milk Oligosaccharides","volume":"81","author":"Xiao","year":"2016","journal-title":"J. Org. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01061203","article-title":"Derivatization procedures for reducing oligosaccharides, part 2: Chemical transformation of 1-deoxy-1-(4-trifluoroacetamidophenyl)aminoalditols","volume":"5","author":"Kallin","year":"1988","journal-title":"Glycoconj. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/infdis\/jiu523","article-title":"Interleukin 23 produced by myeloid dendritic cells contributes to T-cell dysfunction in HIV type 1 infection by inducing SOCS1 expression","volume":"211","author":"Garg","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/infdis\/jit469","article-title":"HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity","volume":"209","author":"Garg","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"18890","DOI":"10.1074\/jbc.M110.206110","article-title":"Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection","volume":"286","author":"Campbell","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Namdev, P., Patel, S., Sparling, B., and Garg, A. (2021). Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals with Viral Suppression Exhibit Suppressed Innate Immunity to Mycobacterium tuberculosis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.647019"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/096876899294751","article-title":"HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands","volume":"16","author":"Clapham","year":"1999","journal-title":"Mol. Membr. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1073\/pnas.95.7.3857","article-title":"C-C chemokines, pivotal in protection against HIV type 1 infection","volume":"95","author":"Zagury","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ramadhin, J., Silva-Moraes, V., Nagy, T., Norberg, T., and Harn, D. (2021). A Comparison of Two Structurally Related Human Milk Oligosaccharide Conjugates in a Model of Diet-Induced Obesity. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.668217"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Rousseaux, A., Brosseau, C., Le Gall, S., Piloquet, H., Barbarot, S., and Bodinier, M. (2021). Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.680911"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/glycob\/cws074","article-title":"Human milk oligosaccharides: Every baby needs a sugar mama","volume":"22","author":"Bode","year":"2012","journal-title":"Glycobiology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coviro.2014.06.005","article-title":"Glycan-dependent viral infection in infants and the role of human milk oligosaccharides","volume":"7","author":"Etzold","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"18220","DOI":"10.1073\/pnas.1307336110","article-title":"Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk","volume":"110","author":"Fouda","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000108414","article-title":"Inhibition of human immunodeficiency virus type 1 activity by purified human breast milk mucin (MUC1) in an inhibition assay","volume":"93","author":"Habte","year":"2008","journal-title":"Neonatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/978-0-387-74087-4_18","article-title":"Potential anti-inflammatory and anti-infectious effects of human milk oligosaccharides","volume":"606","author":"Kunz","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3945\/jn.113.187799","article-title":"Human milk oligosaccharides differ between HIV-infected and HIV-uninfected mothers and are related to necrotizing enterocolitis incidence in their preterm very-low-birth-weight infants","volume":"144","author":"Autran","year":"2014","journal-title":"J. Nutr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3945\/jn.114.199794","article-title":"Oligosaccharide composition of breast milk influences survival of uninfected children born to HIV-infected mothers in Lusaka, Zambia","volume":"145","author":"Kuhn","year":"2015","journal-title":"J. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10868","DOI":"10.1128\/JVI.01702-15","article-title":"Breast Milk of HIV-Positive Mothers Has Potent and Species-Specific In Vivo HIV-Inhibitory Activity","volume":"89","author":"Wahl","year":"2015","journal-title":"J. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1074\/jbc.272.11.6854","article-title":"HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5","volume":"272","author":"Farzan","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.pmbts.2018.10.001","article-title":"Mutations in chemokine receptors and AIDS","volume":"161","author":"Kou","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Barboric, M., and Peterlin, B.M. (2005). A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation. PLoS Biol., 3.","DOI":"10.1371\/journal.pbio.0030076"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tig.2008.03.008","article-title":"Cracking the RNA polymerase II CTD code","volume":"24","author":"Egloff","year":"2008","journal-title":"Trends Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni.1858","article-title":"HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells","volume":"11","author":"Gringhuis","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1128\/JVI.00421-07","article-title":"MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands","volume":"81","author":"Meier","year":"2007","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/j.1460-2075.1993.tb06029.x","article-title":"A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation","volume":"12","author":"Perkins","year":"1993","journal-title":"EMBO J."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Campbell, G.R., Rawat, P., Bruckman, R.S., and Spector, S.A. (2015). Human Immunodeficiency Virus Type 1 Nef Inhibits Autophagy through Transcription Factor EB Sequestration. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005018"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1083\/jcb.200903070","article-title":"Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages","volume":"186","author":"Kyei","year":"2009","journal-title":"J. Cell Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11866","article-title":"Identification of a candidate therapeutic autophagy-inducing peptide","volume":"494","author":"Sumpter","year":"2013","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Biasizzo, M., and Kopitar-Jerala, N. (2020). Interplay Between NLRP3 Inflammasome and Autophagy. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.591803"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"40817","DOI":"10.18632\/oncotarget.17256","article-title":"Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFkappaB pathways in autophagy- and p62-dependent manners","volume":"8","author":"Ko","year":"2017","journal-title":"Oncotarget"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/B:DRUG.0000036685.72140.03","article-title":"Phase I\/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs","volume":"22","author":"Chang","year":"2004","journal-title":"Investig. New Drugs"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Cloughesy, T.F., Yoshimoto, K., Nghiemphu, P., Brown, K., Dang, J., Zhu, S., Hsueh, T., Chen, Y., Wang, W., and Youngkin, D. (2008). Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050008"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1200\/JCO.2005.23.622","article-title":"Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A North Central Cancer Treatment Group Study","volume":"23","author":"Galanis","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1200\/JCO.2004.08.116","article-title":"Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer","volume":"22","author":"Raymond","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-2275(20)42651-3","article-title":"Cellularity of rat adipose tissue: Effects of growth, starvation, and obesity","volume":"10","author":"Hirsch","year":"1969","journal-title":"J. Lipid Res."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/5\/890\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:45:48Z","timestamp":1760028348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/5\/890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,2]]},"references-count":85,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["nu17050890"],"URL":"https:\/\/doi.org\/10.3390\/nu17050890","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,2]]}}}